Nisoldipine — Discount Pricing
Nisoldipine is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Nisoldipine Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $55.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Nisoldipine
Nisoldipine is a prescription medication. Ask your doctor if Nisoldipine is right for you.
How to Check Nisoldipine Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Nisoldipine at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Heart & Cardiovascular
About Nisoldipine
High blood pressure is a silent threat, but medications like nisoldipine can help keep it in check. This calcium channel blocker is a powerful tool in cardiovascular health management. Understanding your treatment options and how to afford them is crucial. With TheDrugClub, you can access significant savings on prescriptions like nisoldipine, making your health journey more manageable and less costly.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Nisoldipine is approved for (FDA label)
Nisoldipine extended-release tablets are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.
Source: Read the full FDA label on DailyMed. Label effective date: June 8, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Nisoldipine (FDA label)
ADVERSE EXPERIENCES More than 6,000 patients world-wide have received nisoldipine in clinical trials for the treatment of hypertension, either as the immediate release or the nisoldipine extended release formulation. Of about 1,500 patients who received nisoldipine extended-release tablets in hypertension studies, about 55% were exposed for at least 2 months and about one third were exposed for over 6 months, the great majority at doses equivalent to 17 mg and above. Nisoldipine extended-release tablets are generally well-tolerated. In the U.S. clinical trials of nisoldipine extended-release tablets in hypertension, 10.9% of the 921 nisoldipine extended-release tablets patients discontinued treatment due to adverse events compared with 2.9% of 280 placebo patients.
Source: FDA prescribing information (DailyMed). Set ID: a52b773a-44f9-442f-a4be-39f79a558bd2. SPL document ID: cef2c469-9a1b-46f3-b08f-57ea2876311f. Label effective date: June 8, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.